CHAPTER 1 INTRODUCTION
1.1 Report Description
1.2 Key Benefits
1.3 Key Market Segments
1.4 Research Methodology
1.4.1 Secondary Research
1.4.2 Primary Research
1.4.3 Analyst Tools and Models
CHAPTER 2 EXECUTIVE SUMMARY
2.1 CXO perspective
CHAPTER 3 MARKET OVERVIEW
3.1 Market definition and scope
3.2 Key findings
3.2.1 Top investment pockets
3.3 Porters Five Forces Analysis
3.3.1 Bargaining power of suppliers
3.3.2 Bargaining power of buyers
3.3.3 Threat of new entrants
3.3.4 Intensity of rivalry
3.3.5 Threat of substitutes
3.4 Market share analysis, 2015
3.5 Government Regulations
3.5.1 U.S. FDA
3.5.2 Europe CE Mark
3.5.3 Ministry of Health, Labour and Welfare (MHLW)
3.6 Reimbursement Scenario
3.7 Clinical Trials
3.8 Market dynamics
3.8.1 Drivers
3.8.1.1 Rise in prevalence of aortic stenosis coupled with increase in geriatric population
3.8.1.2 Increase in adoption rate for transcatheter aortic valve implantation procedure
3.8.1.3 Increasing clinical evidence of safety and efficacy and new device approvals
3.8.1.4 Increase in number of TAVR Centers
3.8.2 Restraints
3.8.2.1 High cost of the device and unfavorable reimbursement policies
3.8.2.2 Stringent regulatory approval process
3.8.3 Opportunities
3.8.3.1 Use of TAVI systems for new indications
3.8.3.2 Rise in expenditure in healthcare and emergence in developing countries
3.8.3.3 Increase in interest of local to global players in the TAvi market
CHAPTER 4 WORLD TRANSCATHETER AORTIC VALVE IMPLANTATION MARKET, BY PROCEDURE
4.1 Overview
4.1.1 Key market trends
4.1.2 Key growth factors and opportunities
4.1.3 Market size and forecast
4.2 Transfemoral (TF) Implantation
4.2.1 Market size and forecast
4.3 Transapical (TA) Implantation
4.3.1 Market size and forecast
4.4 Transaortic Implantation
4.4.1 Market size and forecast
CHAPTER 5 WORLD TRANSCATHTER AORTIC VALVE IMPLANTATION MARKET, BY GEOGRAPHY, 2014-2022
5.1 Overview
5.1.1 Market size and forecast
5.2 North America
5.2.1 Key market trends
5.2.2 Key growth factors and opportunities
5.2.3 Market size and forecast
5.2.4 U.S.
5.2.4.1 Market size and forecast
5.2.5 Canada
5.2.5.1 Market size and forecast
5.2.6 Mexico
5.2.6.1 Market size and forecast
5.3 Europe
5.3.1 Key market trends
5.3.2 Key growth factors and opportunities
5.3.3 Market size and forecast
5.3.4 Germany
5.3.4.1 Market size and forecast
5.3.5 France
5.3.5.1 Market size and forecast
5.3.6 UK
5.3.6.1 Market size and forecast
5.3.7 Italy
5.3.7.1 Market size and forecast
5.3.8 Switzerland
5.3.8.1 Market size and forecast
5.3.9 Rest of Europe
5.3.9.1 Market size and forecast
5.4 Asia-Pacific
5.4.1 Key market trends
5.4.2 Key growth factors and opportunities
5.4.3 Market size and forecast
5.4.4 India
5.4.4.1 Market size and forecast
5.4.5 China
5.4.5.1 Market size and forecast
5.4.6 Japan
5.4.6.1 Market size and forecast
5.4.9 Rest of Asia-Pacific
5.4.9.1 Market size and forecast
5.5 LAMEA
5.5.1 Key market trends
5.5.2 Key growth factors and opportunities
5.5.3 Market size and forecast
5.5.4 Brazil
5.5.4.1 Market size and forecast
5.5.5 Israel
5.5.5.1 Market size and forecast
5.5.6 Saudi Arabia
5.5.6.1 Market size and forecast
5.5.7 South Africa
5.5.7.1 Market size and forecast
5.5.8 Rest of LAMEA
5.5.8.1 Market size and forecast
CHAPTER 6 COMPANY PROFILES
6.1 BOSTON SCIENTIFIC CORPORATION
6.1.1 Company Overview
6.1.2 Company Snapshot
6.1.3 Operating Business Segments
6.1.4 Business Performance
6.1.5 Key Strategic Moves & Developments
6.2 Direct Flow Medical, Inc.
6.2.1 Company Overview
6.2.2 Company Snapshot
6.2.3 Operating Business Segments
6.2.4 Key Strategic Moves & Developments
6.3 Edwards Lifesciences Corporation
6.3.1 Company Overview
6.3.2 Company Snapshot
6.3.3 Operating Business Segments
6.3.4 Business Performance
6.3.5 Key Strategic Moves & Developments
6.4 HLT, Inc.
6.4.1 Company Overview
6.4.2 Operating Business Segments
6.5 JenaValve Technology, Inc.
6.5.1 Company Overview
6.5.2 Company Snapshot
6.5.3 Operating Business Segments
6.6 Medtronic plc
6.6.1 Company Overview
6.6.2 Company Snapshot
6.6.3 Operating Business Segments
6.6.4 Business Performance
6.6.5 Key Strategic Moves & Developments
6.7 Meril Life Sciences Pvt. Ltd.
6.7.1 Company Overview
6.7.2 Company Snapshot
6.7.3 Operating Business Segments
6.8 St. Jude Medical, Inc.
6.8.1 Company Overview
6.8.2 Company Snapshot
6.8.3 Operating Business Segments
6.8.4 Business Performance
6.8.5 Key Strategic Moves And Developments
6.9 SYMETIS SA
6.9.1 Company Overview
6.9.2 Company Snapshot
6.9.3 Operating Business Segments
6.9.4 Key Strategic Moves & Developments
6.10 Transcatheter Technologies GmbH
6.10.1 Company Overview
6.10.2 Company Snapshot
6.10.3 Operating Business Segments
6.10.4 Key Strategic Moves & Developments
